FDA Approved: CLOPIDOGREL — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for clopidogrel from Amneal Pharmaceuticals LLC under the ANDA process (generic product).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction
• Peripheral Artery Disease
• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

SUPPL AP for CLOPIDOGREL (CLOPIDOGREL)